This assessment evaluates the protective barrier of your body—skin, hair, and nails—and how environmental or systemic factors affect them. Please answer as accurately as possible.
Patient identifier (code, initials, or preferred alias)
Assessment date
Primary reason for today’s assessment
Who requested this assessment?
Self-referred
Primary-care clinician
Dermatologist
Other specialist
Insurance/Occupational health
Research study
How would you rate your overall skin condition today?
Excellent
Good
Fair
Poor
Very poor
Have you noticed any new or changing lesions in the past 3 months?
Describe location, size, color, and any symptoms (itch, pain, bleeding).
Which skin sensations have you experienced recently?
Itching (pruritus)
Burning
Stinging
Tightness
Numbness
Tingling
None of the above
Rate average itch severity over the past week (0 = no itch, 10 = worst imaginable).
0
1
2
3
4
5
6
7
8
9
10
Does your skin disease affect sleep?
On average, how many nights per week?
Record observed dermatological signs. If you are the patient, describe what you see or feel.
Select all primary skin lesions present:
Macule
Patch
Papule
Plaque
Nodule
Vesicle
Bulla
Pustule
Wheal
Cyst
Petechiae
Purpura
Telangiectasia
None observed
Select all secondary skin lesions present:
Scale
Crust
Erosion
Ulcer
Fissure
Atrophy
Scar
Lichenification
Hyperpigmentation
Hypopigmentation
Erythema
Excoriation
None observed
Overall lesion distribution pattern
Localized
Regional
Generalized
Symmetric
Asymmetric
Photodistributed
Acral (hands/feet)
Flexural
Extensor
Intertriginous
Follicular based
Dermatomal
None
Describe the most concerning lesion (site, size, border, color, surface change).
Is there oozing, bleeding, or crusting from any lesion?
Dermatoscope or Wood’s lamp used?
Not used
Used—normal findings
Used—abnormal findings
Planned but not yet done
Any scalp itching, scaling, or pain?
Detail location, severity, and any hair loss associated.
Noticeable hair thinning or shedding?
Pattern of hair loss
Diffuse
Frontal/temporal
Vertex/crown
Patchy
Total (alopecia universalis)
Nail changes observed:
Brittleness
Pitting
Ridging (longitudinal)
Ridging (transverse/beau lines)
Onycholysis
Subungual hyperkeratosis
Discoloration
Clubbing
Splinter hemorrhages
Paronychia
None
Upload clinical photographs of scalp, hair, or nail abnormalities (optional).
Recent exposures (within past 6 months):
New personal-care products
Topical antibiotics/steroids
Hair dye or chemical straighteners
Occupational solvents/degreasers
Excessive water/soap
Heavy sweating/occlusive wear
Hot humid climate
Cold dry climate
UV radiation (tanning/sun)
Airborne pollutants
None of the above
Do you smoke tobacco or use vaping products?
Specify product type and daily frequency.
Any new medications or supplements in the past 3 months?
List medications/supplements
Product name | Dose | Start date | Indication | ||
|---|---|---|---|---|---|
A | B | C | D | ||
1 | |||||
2 | |||||
3 | |||||
4 | |||||
5 | |||||
6 | |||||
7 | |||||
8 | |||||
9 | |||||
10 |
Any family history of skin cancer, psoriasis, eczema, or autoimmune blistering disorders?
Select chronic conditions you currently manage:
Diabetes mellitus
Hypertension
Thyroid disease
Atopic dermatitis
Psoriasis
Asthma
Allergic rhinitis
Autoimmune disease (specify)
HIV or immunosuppression
Chronic kidney disease
None
Do you follow any specific diet (vegan, gluten-free, low-histamine, etc.)?
Describe the diet and duration.
Average nightly sleep duration
< 5 h
5–6 h
6–7 h
7–8 h
> 8 h
Highly variable
Rate your average stress level over the past month.
Very low
Low
Moderate
High
Very high
Over the past week, how much has your skin condition affected each of the following?
Not at all | A little | A lot | Very much | |
|---|---|---|---|---|
Symptoms (pain, itch, soreness, bleeding) | ||||
Embarrassment or self-consciousness | ||||
Interference with shopping/home activities | ||||
Choice of clothing | ||||
Social/leisure activities | ||||
Sport/exercise | ||||
Work/study difficulties | ||||
Problems with close relationships | ||||
Sexual difficulties | ||||
Treatment burden (time, mess, side-effects) |
Consent to store anonymized clinical photos for medical documentation?
I understand photos may be used for education or research under strict anonymity.
Recommended review interval
2 weeks
4 weeks
3 months
6 months
1 year
As needed
Outline management plan and patient education provided today.
Clinician/patient signature confirming accuracy of information
Analysis for Integumentary & Dermatological Assessment Form
Important Note: This analysis provides strategic insights to help you get the most from your form's submission data for powerful follow-up actions and better outcomes. Please remove this content before publishing the form to the public.
The Integumentary & Dermatological Assessment Form is expertly engineered to capture a 360-degree view of cutaneous health while respecting clinical workflow efficiency. By integrating validated quality-of-life metrics (DLQI adaptation), structured lesion taxonomies, and environmental exposure histories, the form transforms subjective complaints into objective, longitudinal data that can track therapeutic response or disease progression.
Its modular sectioning mirrors the natural sequence of a dermatologic encounter—context, history, examination, adjunctive structures, exposures, systemic correlates, and follow-up—thereby reducing cognitive load for both patient and clinician. Conditional logic (e.g., follow-up questions triggered only on "yes" responses) minimizes unnecessary fields, cutting completion time and abandonment risk.
Privacy safeguards are woven in through anonymized identifiers, optional photography, and granular consent, ensuring GDPR/HIPAA alignment without sacrificing data richness. The inclusion of image upload and digital signature future-proofs the form for tele-dermatology and value-based care audits.
This question balances identity verification with privacy—critical in dermatology where photographs may later be matched to the record. Allowing aliases empowers adolescents, stigmatized workers, or research participants to engage without fear of re-identification. The placeholder format "JD-2025-06" subtly teaches users to create unique yet anonymous strings, improving downstream data-linkage quality.
From a data-collection standpoint, the field is lightweight (single-line text) yet semantically powerful: it serves as the primary key for merging subsequent images, lab results, and follow-up surveys. Because it is the first mandatory element, it also acts as a soft gatekeeper—users who hesitate at privacy concerns self-select out early, protecting the database from incomplete entries.
User-experience friction is minimal because the placeholder provides a cognitive template; however, the form could be enhanced with real-time validation (regex pattern) to prevent duplicates or insecure identifiers like "1234".
Time-stamping is non-negotiable in dermatology—lesion evolution is measured in weeks to months, and accurate intervals determine biopsy urgency or malignancy surveillance guidelines. By enforcing a calendar picker, the form eliminates ambiguous date formats that plague international registries.
The question also anchors the patient’s temporal memory: when combined with "new or changing lesions," clinicians can calculate incubation periods for drug eruptions or photodistributed flares, vastly improving causality algorithms.
Data-quality implications are profound: a missing or erroneous date invalidates longitudinal photo comparisons and survival analyses. The mandatory flag therefore acts as a hard stop against silent data corruption.
This open-text field captures the patient’s voice—a medico-legal necessity that also drives triage urgency. Unlike checkboxes, free text preserves idiomatic descriptions ("my mole is itching when I sweat") that may harbor red-flag semantics for melanoma.
From a workflow perspective, the answer populates the chief complaint in the EMR, sparing clinicians re-documentation. NLP pipelines can later mine this field for adverse-event signal detection in post-marketing drug surveillance.
The placeholder examples ("new rash on arms, chronic eczema follow-up, nail discoloration") subtly educate patients on granularity, reducing vague entries like "skin problem" and thereby boosting clinical utility.
Understanding referral source stratifies risk: self-referrals often correlate with benign cosmetic concerns, whereas specialist or occupational-health requests may imply malignancy screening or workers’ compensation claims. This metadata is invaluable for resource allocation and audit trails.
Insurance-mandated assessments carry different documentation requirements; capturing this up-front prevents downstream claim rejections and ensures CPT coding accuracy.
The single-choice constraint standardizes categories for analytics while remaining exhaustive enough to cover tele-dermatology triage and research cohorts.
A global Likert snapshot provides a quick patient-reported outcome that correlates moderately with objective severity indices (e.g., EASI, PASI). When tracked over visits, it yields responsiveness metrics for value-based contracts.
The question also serves as a cognitive warm-up, acclimating patients to subjective scales before the more granular DLQI matrix. Positioning it early prevents acquiescence bias that can accumulate when patients tire later in the form.
Data collectors benefit from its universality across diseases—unlike lesion counts, this item applies equally to acne, psoriasis, or contact dermatitis, enabling cross-cohort benchmarking.
This is the melanoma sentinel question. The 3-month window aligns with AJCC guidelines for rapid growth detection, and the yes/no gating funnels high-risk patients into detailed free-text description, enabling teledermoscopy triage.
The follow-up textarea is deliberately multiline, encouraging dimensions, color heterogeneity, and symptoms—features that feed directly into the 7-point checklist for malignancy risk stratification.
Mandatory status ensures zero false negatives; even patients with poor insight are forced to pause and inspect, increasing early-detection yield at population level.
The form’s cardinal strength lies in its clinical realism: every mandatory item is a data point that directly influences diagnostic or billing decisions, eliminating academic clutter. Conditional branching, image upload, and digital signature create a closed-loop ecosystem suitable for both in-office and asynchronous care.
Weaknesses are minor but actionable: (1) optional fields such as lesion distribution pattern or medication table could be made conditionally mandatory based on prior answers to sharpen analytics; (2) the absence of validated body-site mannequins may reduce inter-rater reliability for localization; (3) no adaptive questioning (e.g., hiding nail questions when "no nail changes" is selected) slightly lengthens completion time. Nonetheless, the form achieves an optimal balance between comprehensiveness and user burden, positioning it as a best-practice template for modern dermatologic data capture.
Mandatory Question Analysis for Integumentary & Dermatological Assessment Form
Important Note: This analysis provides strategic insights to help you get the most from your form's submission data for powerful follow-up actions and better outcomes. Please remove this content before publishing the form to the public.
Patient identifier (code, initials, or preferred alias)
Justification: A unique yet de-identified token is the linchpin for linking photographs, follow-up visits, and laboratory data while preserving patient privacy. Without it, duplicate or orphaned records would proliferate, undermining both clinical safety and research integrity.
Assessment date
Justification: Accurate temporal anchoring is mandatory for melanoma surveillance intervals, drug-eruption incubation calculations, and photo-chronological comparisons. Missing or incorrect dates invalidate longitudinal analyses and may breach regulatory standards for malignancy follow-up.
Primary reason for today’s assessment
Justification: Captures the patient-voiced chief complaint in free text, enabling triage urgency algorithms and medico-legal documentation. This field directly feeds the EMR and determines whether same-day biopsy or routine follow-up is scheduled.
Who requested this assessment?
Justification: Referral source drives CPT coding, insurance authorization, and risk stratification. Occupational-health requests, for example, trigger specific documentation to satisfy workers’ compensation statutes, whereas self-referrals may cue cosmetic counseling pathways.
How would you rate your overall skin condition today?
Justification: Provides a quick patient-reported global severity metric that correlates with quality-of-life instruments and satisfies value-based care outcome reporting requirements. Its mandatory status ensures no loss of responsiveness data across visits.
Have you noticed any new or changing lesions in the past 3 months?
Justification: This is the primary screening trigger for potential malignancy. A mandatory yes/no gate guarantees that every patient consciously surveys their skin, and the follow-up description supplies teledermatologists with the granularity needed for rapid triage decisions.
The form adopts a minimal-viable-mandatory philosophy: only six fields are required, each representing a non-negotiable node for safety, billing, or longitudinal analysis. This restraint maximizes form-completion rates while safeguarding data integrity. To further optimize, consider converting lesion distribution and medication history to conditionally mandatory when prior answers indicate moderate-to-severe disease or new drug exposure. Implement real-time validation on the identifier field to prevent weak aliases, and add a progress bar that explicitly labels optional sections, thereby setting user expectations and reducing mid-form abandonment.
To configure an element, select it on the form.